China Money Network
Login
Join

I-Mab Unveils Strategic Changes, Hong Kong IPO Plans, and Rebrands to NovaBridge Biosciences

  • October 17, 2025 — 04:25 CST

This Data Is Locked!

This area is available only to Subscribers.

I-Mab, a global biotechnology platform company, announced a shift in strategy to focus on business development and translational clinical development aimed at getting innovative medicines... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: